Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

61.61
BATS BZX Real-Time Price
As of 12:25pm ET
 +0.17 / +0.28%
Today’s Change
45.45
Today|||52-Week Range
71.60
+4.00%
Year-to-Date
Sohn Preview: What Will Larry Robbins, John Khoury & Carson Block Present Wednesday?
7:44am / TheStreet.com
Worried About Social Security? Buy These 4 Stocks
Apr 26 / MotleyFool.com
Good News: Gilead Sciences Discounted Its Drugs Again
May 02 / MotleyFool.com
5 Biotech Stocks to Bet on This Earnings Season
Apr 25 / Zacks.com
Sohn Preview: What Will Larry Robbins, John Khoury & Carson Block Present Wednesday?
May 02 / TheStreet.com
Healthcare: Britain, the test tube of the world
Apr 25 / FT.com
AbbVie (ABBV) Earnings Report: Q1 2016 Conference Call Transcript
Apr 29 / TheStreet.com
Centene (CNC) Q1 Earnings: Surprise in Store for Stock?
Apr 25 / Zacks.com
AbbVie (ABBV) Stock Price Target Hiked at Jefferies
Apr 29 / TheStreet.com
Aetna (AET) Q1 Earnings: Is a Surprise in Store for Stock?
Apr 25 / Zacks.com
M&A: back with a bang
Apr 29 / FT.com
Big Drug Stocks to Report This Week: LLY, GSK, VRTX, BMY, ABBV
Apr 25 / Zacks.com
Capture A Potential 35% Gain With This Fast-Growing Stock
Apr 28 / StreetAuthority
3 Things to Watch in Gilead Sciences, Inc.'s First-Quarter Results
Apr 23 / MotleyFool.com
Cramer: Worst May Be Over for Embattled Pharma
Apr 28 / TheStreet.com
AbbVie (ABBV) Likely to Beat on Q1 Earnings: Stock to Gain?
Apr 22 / Zacks.com
Three pharma deals worth $45bn reignite M&A boom
Apr 28 / FT.com
Roche (RHHBY) Beats on Q1 Sales, New Launches in Focus (revised)
Apr 21 / Zacks.com
$40 Billion Takeover Has Big Pharma Giddy
Apr 28 / TheStreet.com
The Zacks Analyst Blog Highlights: Medivation, Synta, AbbVie, Gilead and Orexigen
Apr 21 / Zacks.com
AbbVie joins wave of pharma moves with Stemcentrx deal
Apr 28 / FT.com
Better Buy: Pfizer Inc. vs. AbbVie
Apr 21 / MotleyFool.com
The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie ...
Apr 28 / Zacks.com
Biotech Stock Roundup: Medivation Buyout Rumors Resurface, Synta Up on Merger Deal
Apr 20 / Zacks.com
Will Poor Earnings Bring Down the Market?
Apr 28 / TheStreet.com
Healthcare ETFs to Buy on Blockbuster J&J Q1 Results
Apr 20 / Zacks.com
AbbVie (ABBV) Beats on 1Q Earnings, Lowers View on Deal
Apr 28 / Zacks.com
UK companies more likely to hire outside CEOs
Apr 18 / FT.com
AbbVie (ABBV) Tops 1Q Earnings Estimates, Announces Deal
Apr 28 / Zacks.com
M&A deals worth $370bn torpedoed by Obama administration
Apr 07 / FT.com
AbbVie (ABBV) Stock Tumbles, Revises 2016 Outlook to Reflect Stemcentrx Acquisition
Apr 28 / TheStreet.com
US Treasury shatters Pfizer chief Ian Read's merger dreams
Apr 06 / FT.com
AbbVie (ABBV) Lagging In Pre-Market Activity
Apr 28 / TheStreet.com
Big pharma seeks digital solution to productivity problem
Apr 06 / FT.com
Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta, Catalyst Plunge on Regula...
Apr 27 / Zacks.com
Drugmakers race to prescribe preventive migraine remedies
Apr 03 / FT.com
Biotech Stock Gilead (GILD) Likely to Beat in Q1 Earnings
Apr 26 / Zacks.com